Dr. Rup Tandan, MD

Dr. Tandan practices at University of Vermont Medical Center in Burlington, Vermont, part of University of Vermont Health Network.

Dr. Tandan's NPI, 1083631865, was assigned on July 16, 2006. Dr. Tandan graduated from King George's/CSM Medical College in 1970. Dr. Tandan holds Vermont license 42-0006993.

Dr. Tandan's primary practice is University of Vermont Medical Center, at 111 Colchester Ave, Burlington, VT 05401 in Chittenden County. The practice phone is (802) 847-0000.

Dr. Tandan's primary practice is University of Vermont Medical Center in Burlington, Vermont, part of University of Vermont Health Network. The medical group on file is University of Vermont Medical Center. Dmand AI also links Dr. Tandan to 1 more dialysis center, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Tandan practices, 2 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Tandan's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dmand AI has Dr. Tandan's licenses on file in 2 states: Vermont and New York.

CMS data shows 45 Medicare services from Dr. Tandan across 2 procedure codes in 2024, all of them office visits, for 70 Medicare patients. Medicare paid $3,857 for them.

CMS counts 70 Medicare patients who saw Dr. Tandan in 2024. The largest group is 75 to 84, with 30 patients. 70% of them have high blood pressure, and 70% have high cholesterol. 23% are also on Medicaid. Their average risk score is 1.63, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Tandan's median patient age at 73, with 53% women.

In 2024, Dr. Tandan wrote 240 Medicare Part D claims for 33 patients. 50% of them were for generic drugs. CMS names the drug for 190 of them, across 5 drugs with 11 or more claims each, at $1,123,203 in total drug cost. In 2023, CMS named 305 claims across 9 drugs.

Dr. Tandan accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 49 papers to Dr. Tandan, published from 2007 to 2024. 2017 was the busiest year, with 5. The most frequent topics are Amyotrophic Lateral Sclerosis, Disease Progression and Immunoglobulins, Intravenous. Dr. Tandan has published most often in Muscle Nerve. Dr. Tandan's most frequent co-authors are Waqar Waheed, MD, Edward Joseph Kasarskis, MD and Walter G. Bradley.

Dmand AI links Dr. Tandan to 4 clinical trials, 2 of them phase 2 studies. Conditions studied include Myasthenia Gravis, Neuromuscular Junction Diseases and Postpoliomyelitis Syndrome. Grifols Therapeutics LLC sponsors the most, 2. Open Payments lists research payments to Dr. Tandan that name 1 trial.

CMS Open Payments shows 75 general payments to Dr. Tandan from 8 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 55% of the total. Alexion Pharmaceuticals, Inc. paid the most, $19,071. It also lists 17 research payments totaling $6,674 from 2019 to 2025, naming 1 clinical trial.

Dr. Tandan graduated from King George's/CSM Medical College in 1970.